In last trading session, OKYO Pharma Limited (NASDAQ:OKYO) saw 0.31 million shares changing hands with its beta currently measuring -0.08. Company’s recent per share price level of $2.99 trading at $0.09 or 3.10% at ring of the bell on the day assigns it a market valuation of $111.89M. That closing price of OKYO’s stock is at a discount of -4.01% from its 52-week high price of $3.11 and is indicating a premium of 72.91% from its 52-week low price of $0.81. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 73210.0 shares which gives us an average trading volume of 184.41K if we extend that period to 3-months.

For OKYO Pharma Limited (OKYO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.

OKYO Pharma Limited (NASDAQ:OKYO) trade information

OKYO Pharma Limited’s shares saw a change of 91.05% in year-to-date performance and have moved 6.41% in past 5-day. OKYO Pharma Limited (NASDAQ:OKYO) showed a performance of 35.29% in past 30-days. Number of shares sold short was 0.19 million shares which calculate 0.8 days to cover the short interests.

OKYO Pharma Limited (NASDAQ:OKYO)’s Major holders

Insiders are in possession of 34.41% of company’s total shares while institution are holding 6.13 percent of that, with stock having share float percentage of 9.35%. Investors also watch the number of corporate investors in a company very closely, which is 6.13% institutions for OKYO Pharma Limited that are currently holding shares of the company.